- Home
- GDYN vs CLDX Comparison
GDYN vs CLDX Comparison
Compare GDYN & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDYN
- CLDX
- Stock Information
- Founded
- GDYN 2006
- CLDX N/A
- Country
- GDYN United States
- CLDX United States
- Employees
- GDYN N/A
- CLDX N/A
- Industry
- GDYN Computer Software: Prepackaged Software
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GDYN Technology
- CLDX Health Care
- Exchange
- GDYN Nasdaq
- CLDX Nasdaq
- Market Cap
- GDYN 1.1B
- CLDX 1.3B
- IPO Year
- GDYN N/A
- CLDX 2008
- Fundamental
- Price
- GDYN $10.38
- CLDX $22.85
- Analyst Decision
- GDYN Strong Buy
- CLDX Buy
- Analyst Count
- GDYN 4
- CLDX 9
- Target Price
- GDYN $18.75
- CLDX $50.00
- AVG Volume (30 Days)
- GDYN 753.0K
- CLDX 1.0M
- Earning Date
- GDYN 07-31-2025
- CLDX 08-07-2025
- Dividend Yield
- GDYN N/A
- CLDX N/A
- EPS Growth
- GDYN 322.00
- CLDX N/A
- EPS
- GDYN 0.13
- CLDX N/A
- Revenue
- GDYN $371,169,000.00
- CLDX $7,559,000.00
- Revenue This Year
- GDYN $21.02
- CLDX N/A
- Revenue Next Year
- GDYN $13.95
- CLDX N/A
- P/E Ratio
- GDYN $81.93
- CLDX N/A
- Revenue Growth
- GDYN 18.72
- CLDX 24.49
- 52 Week Low
- GDYN $10.26
- CLDX $14.40
- 52 Week High
- GDYN $25.50
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- GDYN 28.13
- CLDX 60.24
- Support Level
- GDYN $10.35
- CLDX $20.76
- Resistance Level
- GDYN $12.86
- CLDX $23.55
- Average True Range (ATR)
- GDYN 0.52
- CLDX 1.20
- MACD
- GDYN -0.10
- CLDX 0.17
- Stochastic Oscillator
- GDYN 4.78
- CLDX 76.84
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.